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1. Introduction 
The continuous culture of the human malarial 
parasite Plasmodium falcipantm [l] provides a con- 
venient new method for testing materials for anti- 
malarial activity. Especially suitable for this purpose 
is the petri dish technique [2] . This method has now 
been used to demonstrate a new class of substances 
with antimalarial action, S-isobutyl adenosine (SIBA) 
and certain of its analogues. These analogues of S-ade- 
nosy1 homocysteine have been shown to inhibit several 
oncogenic viruses [3-S] and mitogen-stimulated 
blastogenesis of lymphocytes [6]. 
2. Materials and methods 
Two strains of P. falciparum were used, both after 
prolonged culture in vitro (see Table 1). The parasites 
were grown in human Type AB erythrocytes in culture 
medium RPM1 1640 (Grand Island Biol. Co.) sup- 
plemented with Hepes buffer at 25 mM and 10% 
human Type AB serum. For each experiment a single 
suspension of parasitized cells appropriately diluted 
with fresh uninfected red cells was used for all the 
cultures. These were prepared in 35 mm plastic petri 
dishes, each receiving 1.5 ml 10% red cell suspension. 
The cultures were incubated at 37’C in a candle jar 
and fresh medium was provided daily (see [2] for 
W2 
details). The parasites were exposed to drug either 
from the outset or after 2 days growth in absence of 
drug. 
The compounds tested were 5’deoxy-S’S-isobutyl 
adenosine (SIBA) (where R group attached to the S 
is (CHa)&H-CH*--) [7], an analogue designated as 
Iso SIBA[R is CHa-CHa-CH(CHa)-] and 2-pyridyl- 
S-adenosine [8] (ANVAR-Institut Pasteur patents 
pending). Each was dissolved by grinding 3.7 mg in 
a mortar with 20 ml RPM1 1640 medium containing 
25 mM Hepes but without bicarbonate. The solu- 
tions, at a concentration of 0.5 mM, were sterilized 
by filtration through a glass ultrafilter and stored in a 
refrigerator. Just before use appropriate amounts of sterile 
5% NaHCOa solution and sterile serum were added, 
and desired dilutions made with complete culture 
medium. 
Counts of the parasites were made from dried 
films fixed in methanol and stained with Giemsa’s 
stain. A film was always prepared from the suspen- 
sion used to start the cultures (‘0’ time) and again 
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after 2 days exposure to drug. Further details are given 
in table 1 together with the results of 3 experiments, 
two with SIBA and its analogues and one with chloro- 
quine for purposes of comparison. 
3. Results and discussion 
For both a Southeast Asian and an African strain, 
of P. falcipanrm SIBA was markedly inhibitory at 
300 PM but not at lower concentrations (table 1, 
exps. B and C). This is the same as the concentration 
that gave 94% inhibition of convanavalin A-stimulated 
blastogenesis of lymphocytes [6], somewhat lower 
than the concentration effective against Rous sarcoma 
virus in vitro [3], and higher than the 50 PM concen- 
tration inhibiting polyoma virus growth in mouse 
embryo cells [4]. Iso-SIBA and 2-pyridylS-adeno- 
sine, tested only against the African strain, appeared 
to be slightly less active than SIBA. These results 
indicate how in vitro cultures of PI falciparum can be 
utilized for direct screening for new agents with anti- 
malarial activity against the human parasite. It must 
be recognized, of course, that such screening would 
Table 1 
Inhibition of P. falcipamm in vitro by chloroquine and by S-isobutyl adenoslne 
and two of its analogues 
Exp. Drug Concentration Parasites/lo 000 rbc 
(ctM) after 2 days 
A None _ 250,309,251 av: 212 
Chloroquine (base) 0.10 319,327, av: 323 
0.33 344,291, av: 317 
1 .oo 116,105, av: 111 
B None 
SIBA 
- 172,225,206 av: 201 
30 261,237,191 av: 230 
100 93,245,109 av: 136 
300 17, 25, 23 av: 22 
C 
-- 
None 
SIBA 
ISO-SIBA 
2-pyridylS-adenosine 
- 190,120,176 av: 162 
300 53, 60, 26 av: 46 
180 146,140,130 av: 139 
300 13, 14, 81 av: 76 
180 128,146,202 av: 158 
300 35, 57, 92av: 61 
180 122,162,199 av: 161 
aCounts for each culture dish and averages (av) 
For exps. A and B. strain FVO [ 131 (chloroquine resistant) was used after it had 
been one year in continuous culture (now designated as Strain FCR-1). A petri 
dish culture was diluted with fresh erythrocytes to give an initial parasite count 
of lO/lO 000 red cells and all dishes were prepared from this suspension. They 
were kept ln medium without drug for 2 days. On days 2 and 3, when the medium 
was changed the controls were again given medium without drug whereas the 
experimental dishes were given medium with drug incorporated in it to give the 
indicated concentrations. Slides for counts were made on 4, and hence after 2 days 
of exposure to drug 
For exp. C, strain 6252 (isolated directly in culture from infected human blood 
brought from Gambia, West Africa, by Friedman, M.) was used after it had been 
7 months in culture (now designated Strain FCR4). A flow vessel culture with a 
parasitemia of 5% was diluted with fresh erythrocytes to give a suspension with an 
initial count of 20/10 000 red cells. The experimental dishes were exposed to drug 
from the outset and slides for counts were made 2 days later 
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not reveal agents whose activity depends on metab- 
olic transformation by a host organism, nor does it 
fully obviate the need for drug tests in both infected 
and uninfected animals. In this connection it is of 
interest hat SIBA has been used in intact mice 
infected with Friend virus and gave 40% prolongation 
of life span at a dosage of 1 mg/mouse (Chermann, 
J. C., Institut Pasteur, personal communication). 
Furthermore at 500 PM SIBA had no effect on 
growth of normal mouse embryo cells [4], and at 
1 mM it had only a reversible cytostatic effect on 
normal chick embryo fibroblasts [3]. 
Since SIBA is an inhibitor of transmethylases 
[3,9,10] , its antimalarial effect may depend on this 
activity. Detailed study of the metabolism of P. falci- 
parum in the presence of the drug is needed, and here 
again the in vitro cultures hould be invaluable. 
It will be noted (table 1, exp. A) that chloroquine 
had only a moderate inhibitory effect even at 1 .O PM 
on strain FVO, a known chloroquine-resistant strain. 
Using short term cultures in Aatus rrivirgatus erythro- 
cytes [ 1 l] , the FVO strain was found resistant to chloro 
quine concentrations up to 0.3 pg/ml (about equiv- 
alent to 1 PM). Similarly [12], using short term cul- 
tures in human blood the resistant Vietnam-Marks 
strain was found to be about 50% inhibited by chloro- 
quine at 2-3 PM, whereas 0.2 PM gave the same 
inhibition of the susceptible Uganda-Palo Alto strain. 
Effective plasma levels of chloroquiue for non-resis- 
tant strains of P. falciparum are about 0.1 PM. Con- 
tinuous cultures of P. falciparum should be of special 
use for comparative studies of different strains with 
regard to relative susceptibility to chloroquine and 
other drugs. 
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